Visus Therapeutics Appoints Industry Leaders Tracy Valorie and Dwight Moxie to Board of Directors

SEATTLE--(BUSINESS WIRE)--Visus Therapeutics Inc., a clinical-stage pharmaceutical company developing innovative ophthalmic therapies to improve vision for people around the world, today announced the appointments of Tracy Valorie, former Senior Vice President and General Manager, US Ophthalmology Rx and Surgical at Bausch + Lomb, and Dwight Moxie, Senior Vice President, General Counsel and Corporate Secretary at Revance Therapeutics, Inc., to its Board of Directors. “I am very pleased to welco